ARCHIVES

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

This article is from The Cancer Letter archive.

Vol. 18 No. 03 | January 17, 1992

Download PDF Visit The Full Archive

Related Articles

Patient Advocates Ask HCFA To Clarify Coverage Decision.

September 8, 2000

In Brief: Lasker awards Recognizes Six Scientists; NCAB Honors Vande Woude for Work At NCI

October 1, 1999

Abstracts Of Papers From Copenhagen Leukemia Symposium

October 31, 1975

FDA Orders More Changes In ESA Label,

August 8, 2008

How NCI Plans To Spend Funds In FY 1980

July 14, 1978

In Brief: Newell Tells Advisory Committee It Isn’t a Lobbying Group, “Accept What We Give You”

April 8, 1977